Catalog4 refs
Thymosin Alpha 1 (Ta1)
Immune ModulationResearch use only
Educational use only. Not medical advice. Verify all information with primary sources and a licensed clinician before use.
Body Map
Overview
Synthetic 28-amino acid peptide identical to naturally occurring thymic hormone, studied in 11,000+ patients across 30+ clinical trials with less than 1% serious adverse events. Approved in 35+ countries for immune modulation. Activates TLR pathways, enhances T-cell maturation, stimulates NK cells, and modulates dendritic cell function via systemic circulation.
Primary Uses
Primary Immunodeficiencies
Vaccine Enhancement
HIV/AIDS Support
Cytokine Reduction
Hepatitis B/C Support
Autoimmune Conditions
Post-Surgical Immune Restoration
Exercise-Induced Immunosuppression
Thymic Regeneration Support
Immune Senescence Delay
Protocol Reference
Dose
1.6mg per injection
Frequency
2x weekly
Half-life
~2 hours
Route
Subcutaneous · Intramuscular · Nasal
Evidence
Well Studied
Research Models
Human
Also in Immune Modulation